Supply Capacity. Subject to Section 3.1(a), Novo Nordisk Delivery Technologies, Inc. shall maintain sufficient production capacity for the current and forecasted requirements of Packaged Device and/or Packaged Dosage Form, as set forth in the applicable Forecast as defined below.
Appears in 2 contracts
Sources: Restructuring Agreement (Aradigm Corp), Restructuring Agreement (Aradigm Corp)